FDA Ups Foreign Inspections In Fiscal 07; Visits 11% Of Establishments

Data from a Government Accountability Office report suggest FDA took to heart criticism of its procedures for inspecting foreign drug manufacturers, but is struggling to improve performance given financial pressures